NAFLD in Asia—as common and important as in the West (original) (raw)

• Ludwig, J., Viggiano, T. R., McGill, D. B. & Oh, B. J. Nonalcoholic steatohepatitis; Mayo experience with a hitherto unnamed disease. Mayo Clin. Proc. 55, 434–438 (1980).
  CAS PubMed Google Scholar
• Yoshitoshi, Y. Clinical aspects of fatty liver [Japanese]. Chiryo 46, 1–12 (1964).
  CAS PubMed Google Scholar
• Maruhama, Y. et al. Interactions of obesity and glucose-stimulated insulin secretion in familial hypertriglyceridemia. Diabetes 27, 682–693 (1978).
  CAS PubMed Google Scholar
• Farrell, G. C. NASH: What is it, and why is it important in the Asia–Pacific region? J. Gastroenterol. Hepatol. 18, 124–138 (2003).
  PubMed Google Scholar
• Chitturi, S., Farrell, G. C. & George, J. Non-alcoholic steatohepatitis in the Asia–Pacific region: future shock? J. Gastroenterol. Hepatol. 19, S242–S250 (2004).
  Google Scholar
• Okanoue, T., Umemura, A., Yasui, K. & Itoh, Y. Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis in Japan. J. Gastroenterol. Hepatol. 26 (Suppl. 1), S153–S163 (2011).
  Google Scholar
• Chitturi, S., Wong V. W.-S. & Farrell, G. C. Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground. J. Gastroenterol. Hepatol. 26 (Suppl. 1), S163–S172 (2011).
  Google Scholar
• Wong, V. W. Non-alcoholic fatty liver disease in Asia–A story of growth. J. Gastroenterol. Hepatol. 28, 18–23 (2013).
  PubMed Google Scholar
• Chitturi, S. et al. Non-alcoholic fatty liver disease in the Asia–Pacific region: definitions and overview of proposed guidelines. J. Gastroenterol. Hepatol. 22, 778–787 (2007).
  PubMed Google Scholar
• Farrell, G. C. et al. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia–Pacific region. Executive Summary. J. Gastroenterol. Hepatol. 22, 775–777 (2007).
  PubMed Google Scholar
• Amarapurkar, D. N. et al. How common is non-alcoholic fatty liver disease in the Asia–Pacific region, and are there local differences? J. Gastroenterol. Hepatol. 22, 788–793 (2007).
  PubMed Google Scholar
• Fan J.-G. et al. What are the risk factors for non-alcoholic fatty liver disease in Asia–Pacific? J. Gastroenterol. Hepatol. 22, 794–800 (2007).
  PubMed Google Scholar
• Chan H. L, et al. How should we manage patients with non-alcoholic fatty liver disease in 2007? J. Gastroenterol. Hepatol. 22, 801–808 (2007).
  PubMed Google Scholar
• Ratzui, V., Bellentani, S., Cortez-Pinto, H., Day, C. & Marchesini, G. A position paper on NAFLD/NASH based on the EASL special conference. J. Hepatol. 53, 372–384 (2010).
  Google Scholar
• Chalasani, N. et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55, 2005–2023 (2012).
  PubMed Google Scholar
• Larter, C. Z., Chitturi, S., Heydet, D. & Farrell, G. C. A fresh look at NASH pathogenesis. Part 1: The metabolic movers. J. Gastroenterol. Hepatol. 25, 672–690 (2010).
  CAS PubMed Google Scholar
• Angulo, P. Diagnosing steatohepatitis and predicting liver-related mortality in patients with NAFLD: two distinct concepts. Hepatology 53, 1792–1794 (2011).
  PubMed Google Scholar
• Dunn, W., Xu, R. & Schwimmer, J. B. Modest wine drinking and decreased prevalence of suspected non-alcoholic fatty liver disease. Hepatology 47, 1947–1954 (2008).
  PubMed Google Scholar
• Dunn, W., et al. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). J. Hepatol. 57, 384–391 (2012).
  CAS PubMed PubMed Central Google Scholar
• Dixon, J. B., Bhathal, P. S. & O'Brien, P. E. Nonalcoholic fatty liver disease: predictors of non-alcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121, 91–100 (2001).
  CAS PubMed Google Scholar
• Davies, M. J. et al. Effects of moderate alcohol intake on fasting serum insulin and glucose concentrations and insulin sensitivity in postmenopausal women. JAMA 287, 2559–2562 (2002).
  CAS PubMed Google Scholar
• Di Castelnuovo, A. et al. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch. Int. Med. 166, 2437–2445 (2006).
  Google Scholar
• Hamaguchi, M. et al. Protective effect of alcohol consumption for fatty liver but not metabolic syndrome. World J. Gastroenterol. 18, 156–167 (2012).
  CAS PubMed PubMed Central Google Scholar
• Wong, V. W. et al. Hepatitis B virus infection and fatty liver in the general population. J. Hepatol. 56, 533–540 (2012).
  PubMed Google Scholar
• Shi, J. P. et al. Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection. J. Gastroenterol. Hepatol. 23, 1419–1425 (2008).
  PubMed Google Scholar
• Wong, G. L. et al. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut 58, 111–117 (2009).
  PubMed Google Scholar
• Yakoo, T., Tang, A. & Sirlin, C. in Non-alcoholic fatty liver disease. A practical guide (eds Farrell, G. C., Day, C. P., McCullough, A. J.) Wiley Blackwell 352 pages (in press).
• Saadeh, S. et al. The utility of radiological imaging in non-alcoholic fatty liver disease. Gastroenterology 123, 745–750 (2002).
  PubMed Google Scholar
• Wong, V. W. et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 61, 409–415 (2012).
  PubMed Google Scholar
• Brunt, E. M. & Tiniakos, D. G. Histopathology of non-alcoholic fatty liver disease. World J. Gastroenterol. 16, 5286–5296 (2010).
  PubMed PubMed Central Google Scholar
• Neuschwander-Tetri, B. A. et al. Clinical, laboratory and histological associations in adults with non-alcoholic fatty liver disease. Hepatology 52, 913–924 (2010).
  CAS PubMed Google Scholar
• Younossi, Z. M. et al. Pathologic criteria for non-alcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology 53, 1874–1882 (2011).
  PubMed Google Scholar
• Wong, V. W. et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 51, 454–462 (2010).
  CAS PubMed Google Scholar
• Wong, G. L. et al. Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population. J. Gastroenterol. Hepatol. 26, 300–305 (2011).
  PubMed Google Scholar
• Hashimoto, E., Tokushige, K. & Farrell, G. C. Histological features of non-alcoholic fatty liver disease: what is important? J. Gastroenterol. Hepatol. 27, 5–7 (2012).
  CAS PubMed Google Scholar
• Chalasani, N. et al. Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease. J. Hepatol. 48, 829–834 (2008).
  PubMed PubMed Central Google Scholar
• Guy, C. D. et al. Costaining for keratins 8/18 plus ubiquitin improves detection of hepatocyte injury in nonalcoholic fatty liver disease. Hum. Pathol. 43, 790–800 (2012).
  CAS PubMed Google Scholar
• Ekstedt, M. et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44, 865–873 (2006).
  CAS PubMed Google Scholar
• Argo, C. K., Northup, P. G., Al-Osaimi, A. M. & Caldwell, S. H. Systematic review of risk factors for fibrotic progression in non-alcoholic steatohepatitis. J. Hepatol. 51, 371–379 (2009).
  CAS PubMed Google Scholar
• Adams, L. A., Sanderson, S., Lindor, K. D. & Angulo, P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J. Hepatol. 42, 132–138 (2005).
  PubMed Google Scholar
• Wong, V. W. et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 59, 969–974 (2010).
  PubMed Google Scholar
• Ratziu, V. et al. Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability. Aliment. Pharmacol. Ther. 26, 821–830 (2007).
  CAS PubMed Google Scholar
• Bugianesi, E. et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123, 134–140 (2002).
  PubMed Google Scholar
• Caldwell, S. H. et al. NASH and cryptogenic cirrhosis: a histological analysis. Ann. Hepatol. 8, 346–352 (2009).
  PubMed PubMed Central Google Scholar
• Lee, K. Relationship between uric acid and hepatic steatosis among Koreans. Diabetes Metab. 35, 447–451 (2009).
  CAS PubMed Google Scholar
• Park, S. H. et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J. Gastroenterol. Hepatol. 21, 138–143 (2006).
  PubMed Google Scholar
• Li, Y., Xu, C., Yu, C., Xu, L. & Miao, M. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J. Hepatol. 50, 1029–1034 (2009).
  CAS PubMed Google Scholar
• Fan, J. G. & Farrell, G. C. Epidemiology of non-alcoholic fatty liver disease in China. J. Hepatol. 50, 204–210 (2009).
  PubMed Google Scholar
• Chen, C. H. et al. Prevalence and etiology of elevated serum alanine aminotransferase in an adult population of Taiwan. J. Gastroenterol. Hepatol. 22, 1482–1489 (2007).
  CAS PubMed Google Scholar
• Tsai, C. H., Li, T. C. & Lin, C. C. Metabolic syndrome as a risk factor for non-alcoholic fatty liver disease. South Med. J. 101, 900–905 (2008).
  PubMed Google Scholar
• Lin, Y. C., Chang, P. F., Yeh, S. J., Liu, K. & Chen, H. C. Risk factors for liver steatosis in obese children and adolescents. Pediatr. Neonatol. 51, 149–154 (2010).
  PubMed Google Scholar
• Lee, Y. S., Kek, B. L., Poh, L. K., Saw, S. M. & Loke, K. Y. Association of raised liver transaminases with physical inactivity, increased waist-hip ratio, and other metabolic morbidities in severely obese children. J. Pediatr. Gastroenterol. Nutr. 47, 172–178 (2008).
  CAS PubMed Google Scholar
• Fan, J. G. et al. Fatty liver and the metabolic syndrome among Shanghai adults. J. Gastroenterol. Hepatol. 20, 1825–1832 (2005).
  PubMed Google Scholar
• Mohan, V., Farooq, S., Deepa, M., Ravikumar, R. & Pitchumoni, C. S. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res. Clin. Pract. 84, 84–91 (2009).
  CAS PubMed Google Scholar
• Das, K. et al. Nonobese population in a developing country has a high prevalence of non-alcoholic fatty liver and significant liver disease. Hepatology 51, 1593–1602 (2010).
  CAS PubMed Google Scholar
• Dassanayake, A. S. et al. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population. J. Gastroenterol. Hepatol. 24, 1284–1288 (2009).
  PubMed Google Scholar
• Pinidiyapathirage, M. J. et al. Non-alcoholic fatty liver disease in a rural, physically active, low income population in Sri Lanka. BMC Res. Note 4, 513 (2011).
  Google Scholar
• Magosso, E. et al. Prevalence of non-alcoholic fatty liver in a hypercholesterolemic population of northwestern peninsula Malaysia. Southeast Asian J. Trop. Med. Public Health 41, 936–942 (2010).
  PubMed Google Scholar
• Malik, A., Cheah, P. L., Hilmi, I. N., Chap, S. P. & Goh, K. L. Non-alcoholic fatty liver disease in Malaysia a demographic, anthropometric, metabolic and histologic study. J. Dig Dis. 8, 58–64 (2007).
  CAS PubMed Google Scholar
• Chow, W. C. et al. Significant non-alcoholic fatty liver disease is found in non-diabetic, pre-obese Chinese in Singapore. Singapore Med. J. 48, 752–757 (2007).
  CAS PubMed Google Scholar
• Liu, C. J. Prevalence and risk factors for NAFLD in Asian people who are not obese. J. Gastroenterol. Hepatol. 27, 1555–1560 (2012).
  PubMed Google Scholar
• Yoon K.-H. et al. Epidemic obesity and type diabetes in Asia. Lancet 368, 1681–1688 (2006).
  PubMed Google Scholar
• Chang, Y. et al. Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in health Korean men. Gut 58, 1419–1425 (2009).
  CAS PubMed Google Scholar
• Park, S. H. et al. Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. J. Gastroenterol. Hepatol. 19, 694–698 (2004).
  CAS PubMed Google Scholar
• Weston, S. R. et al. Racial and ethnic distribution of non-alcoholic fatty liver in persons with newly diagnosed liver disease. Hepatology 41, 372–379 (2005).
  PubMed Google Scholar
• Bambha, K. et al. Ethnicity and non-alcoholic fatty liver disease. Hepatology 55, 769–780 (2012).
  CAS PubMed Google Scholar
• Urakami, T. et al. Insulin resistance at diagnosis in Japanese children with type 2 diabetes mellitus. Pediatr. Int. 54, 516–519 (2012).
  CAS PubMed Google Scholar
• Williams, C. D. et al. Prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140, 124–131 (2011).
  PubMed Google Scholar
• Cusi, K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis (NASH): clinical implications. Gastroenterology 142, 711–725 (2012).
  CAS PubMed Google Scholar
• Hamaguchi, M. et al. The metabolic syndrome as a predictor of non-alcoholic fatty liver disease. Ann. Int. Med. 143, 722–728 (2005).
  CAS PubMed Google Scholar
• Wong, V. W. et al. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 24, 1215–1222 (2006).
  CAS PubMed Google Scholar
• Kimura, Y. et al. Postprandial insulin secretion pattern is associated with histological severity in non-alcoholic fatty liver disease patients without prior known diabetes mellitus. J. Gastroenterol. Hepatol. 26, 517–522 (2011).
  CAS PubMed Google Scholar
• Manchanayake, J., Chitturi, S., Nolan, C. & Farrell, G. C. Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease. J. Gastroenterol. Hepatol. 26, 510–516 (2011).
  CAS PubMed Google Scholar
• Chitturi, S. et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35, 373–379 (2002).
  CAS PubMed Google Scholar
• Anjana, R. M. et al. Parental history of type 2 diabetes mellitus, metabolic syndrome and cardiometabolic risk factors in Asian Indian adolescents. Metabolism 58, 344–350 (2009).
  CAS PubMed Google Scholar
• Loomba, R. et al. Association between diabetes, family history of diabetes and risk of non-alcoholic steatohepatitis and fibrosis. Hepatology 56, 943–951 (2012).
  PubMed Google Scholar
• Kasturiratne, A. et al. Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus. J. Gastroenterol. Hepatol. http://dx.doi.org/10.111/j.1440–17462012.07264.x.
• Yamada, T. et al. Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup. J. Gastroenterol. Hepatol. 25, 352–356 (2010).
  CAS PubMed Google Scholar
• Fan, J. G. & Farrell, G. C. Does non-alcoholic fatty liver disease predispose patients to type 2 diabetes in the absence of obesity? J. Gastroenterol. 25, 223–225 (2010).
  CAS Google Scholar
• Shibata, M., Kihara, Y., Taguchi, M., Tashiro, M. & Otsuki, M. Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care 30, 2940–2944 (2007).
  CAS PubMed Google Scholar
• Fan, J. G. et al. Effects of non-alcoholic fatty liver disease on the development of metabolic disorders. J. Gastroenterol. Hepatol. 22, 1086–1091 (2007).
  CAS PubMed Google Scholar
• Sung, K. C., Jeong, W. S., Wild, S. H. & Byrne, C. D. Combined influence of insulin resistance/obesity and fatty liver as risk factors for type 2 diabetes. Diabetes Care 35, 717–722 (2012).
  CAS PubMed PubMed Central Google Scholar
• Angulo, P. et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45, 846–854 (2007).
  CAS PubMed Google Scholar
• Tsang, S. W. et al. Predictors of fibrosis in Asian patients with non-alcoholic steatohepatitis. J. Gastroenterol. Hepatol. 21, 116–121 (2006).
  PubMed Google Scholar
• Noto, H., Osame, K., Sasazuki, T. & Noda, M. Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiological evidence in Japan. J. Diabetes Complications 24, 345–353 (2010).
  PubMed Google Scholar
• Lai, S. W. et al. Risk of hepatocellular carcinoma in diabetic patients and risk reduction with anti-diabetic therapy: a population-based cohort study. Am. J. Gastroenterol. 107, 46–52 (2012).
  CAS PubMed Google Scholar
• Marchesini, G. & Forlani, G. Diabetes and hepatocellular carcinoma: not only a matter of hyperglycemia. Hepatology 55, 1298–1300 (2012).
  PubMed Google Scholar
• Musso, G., Cassader, M., Rosino, F. & Gambino, R. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia 55, 885–904 (2012).
  CAS PubMed Google Scholar
• Lim, J. S., Mietus-Snyder, M., Valente, A., Schwarz, J. M. & Lustig, R. H. The role of fructose in pathogenesis of NAFLD and the metabolic syndrome. Nat. Rev. Gastroenterol. Hepatol. 7, 251–264 (2010).
  CAS PubMed Google Scholar
• Abdelmalek, M. F. et al. Increased fructose consumption is associated with fibrosis severity in patients with non-alcoholic fatty liver disease. Hepatology 51, 1961–1971 (2010).
  CAS PubMed Google Scholar
• Toshimitsu, K. et al. Dietary habits and nutrient intake in non-alcoholic steatohepatitis. Nutrition 23, 46–52 (2007).
  PubMed Google Scholar
• Enjoji, M. & Nakamuta, M. Is the control of dietary cholesterol intake sufficiently effective to ameliorate non-alcoholic fatty liver disease? World J. Gastroenterol. 16, 800–803 (2010).
  CAS PubMed PubMed Central Google Scholar
• Ioannou, G. N., Morrow, O. B., Connole, M. L. & Lee, S. P. Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population. Hepatology 50, 175–184 (2009).
  CAS PubMed Google Scholar
• Farrell G. C. & van Rooyen, D. Liver cholesterol: is it playing possum in NASH? Am. J. Physiol. Gastrointest Liver Physiol. 303, G9–G11 (2012).
  CAS PubMed Google Scholar
• Musso, G., Gambino, R. & Cassader, M. Cholesterol metabolism and the pathogenesis of non-alcoholic fatty liver disease. Prog. Lipid Res. 52, 175–191 (2013).
  CAS PubMed Google Scholar
• Musso, G., Gambino, R., Cassader, M. & Pagano, G. A meta-analysis of randomized trials for the treatment of non-alcoholic fatty liver disease. Hepatology 52, 79–104 (2010).
  CAS PubMed Google Scholar
• Sanyal, A. J. et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N. Engl. J. Med. 362, 1675–1685 (2010).
  CAS PubMed PubMed Central Google Scholar
• Kistler, K. D. et al. Physical activity recommendations, exercise intensity, and histological severity of non-alcoholic fatty liver disease. Am. J. Gastroenterol. 106, 460–468 (2011).
  PubMed PubMed Central Google Scholar
• Thoma, C. & Day, C. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J. Hepatol. 56, 255–266 (2012).
  PubMed Google Scholar
• Jin, J. Y. et al. Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors. J. Gastroenterol. Hepatol. 27, 1341–1347 (2012).
  CAS PubMed Google Scholar
• Romeo, S. et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40, 1461–1465 (2008).
  CAS PubMed PubMed Central Google Scholar
• Speliotes, E. C. et al. Genome-wide association analysis identifies variants associated with non-alcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 7, e1001324. (2011).
  CAS PubMed PubMed Central Google Scholar
• Romeo, S. et al. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life. J. Hepatol. 53, 335–338 (2010).
  CAS PubMed Google Scholar
• Chalasani, N. et al. Genome-wide association study identifies variants associated with histologic features of non-alcoholic fatty liver disease. Gastroenterology 139, 1567–1576 (2010).
  PubMed Google Scholar
• Chen, S., Li, Y., Li, S. & Yu, C. A Val227Ala substitution in the peroxisome proliferator activated receptor α (PPARα) gene associated with non-alcoholic fatty liver disease and decreased waist circumference and waist-hip-ratio. J. Gastroenterol. Hepatol. 23, 1415–1418 (2008).
  CAS PubMed Google Scholar
• Yamakawa-Kobayashi, K., Ishiguro, H., Arinami, T., Miyakzaki, R. & Hamaguchi, H. A Val227Ala polymorphism in the peroxisome proliferator activated receptor α (PPARα) gene is associated with variations in serum lipid levels. J. Med. Genet. 39, 189–191 (2002).
  CAS PubMed Google Scholar
• Adams, L. A. et al. Cholesteryl ester transfer protein gene polymorphisms increase the risk of fatty liver in females independent of adiposity. J. Gastroenterol. Hepatol. 27, 1520–1527 (2012).
  CAS PubMed Google Scholar
• Hui, Y. et al. Effect of peroxisome proliferator-activated receptors-gamma and co-activator-1α genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people. Liver Int. 28, 385–392 (2008).
  PubMed Google Scholar
• Chen, H. H., Lee, W. J., Fann, C. S., Bouchard, C. & Pan, W. H. Severe obesity is associated with novel single nucleotide polymorphisms of the ESR1 and PPARgamma locus in Han Chinese. Am. J. Clin. Nutr. 90, 255–262 (2009).
  CAS PubMed Google Scholar
• Wang, C. W. et al. The PNPLA3 I148M polymorphism is associated with insulin resistance and non-alcoholic fatty liver disease in a normoglycaemic population. Liver Int. 31, 1326–1331 (2011).
  PubMed Google Scholar
• Zain, S. M. et al. A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease. Hum. Genet. 131, 1145–1152 (2012).
  CAS PubMed PubMed Central Google Scholar
• Valenti, L. et al. Homozygosity for the patatin-like phospholipase-3/Adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 51, 1209–1217 (2010).
  CAS PubMed Google Scholar
• Duseja, A. & Aggarwal, R. ApoC3 and PNPLA3 in non-alcoholic fatty liver disease: need to clear the air. J. Gastroenterol. Hepatol. 27, 848–851 (2012).
  CAS PubMed Google Scholar
• Kawaguchi, T. et al. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS ONE 7, e38322 (2012).
  CAS PubMed PubMed Central Google Scholar
• Petersen K. F. et al. Apolipoprotein C3 gene variants in non-alcoholic fatty liver disease. N. Engl. J. Med. 362, 1082–1089 (2010).
  CAS PubMed PubMed Central Google Scholar
• Valenti, L. et al. The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls. BMC Gastroenterol. 12, 111 (2012).
  CAS PubMed PubMed Central Google Scholar
• Wong, V. W. et al. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 4, 1154–1161 (2006).
  CAS PubMed Google Scholar
• Yuan, X. et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am. J. Hum. Genet. 83, 520–528 (2008).
  CAS PubMed PubMed Central Google Scholar
• Stickel, F. & Hampe, J. Genetic determinants of alcoholic liver disease. Gut 61, 150–159 (2012).
  CAS PubMed Google Scholar
• Tian, C., Stokowski, R. P., Kershenobich, D., Ballinger, D. G. & Hinds, D. A. Variant in PNPLA3 is associated with alcoholic liver disease. Nat. Genet. 42, 21–23 (2010).
  CAS PubMed Google Scholar
• Xin, Y. N. et al. Molecular dynamics simulation of PNPLA3 I148M polymorphism reveals reduced substrate access to the catalytic cavity. Proteins 81, 406–414 (2012).
  PubMed Google Scholar
• Li, J. Z. et al. Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis. J. Clin. Invest. 122, 4130–4144 (2012).
  CAS PubMed PubMed Central Google Scholar
• Pirazzi, C. et al. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro. J. Hepatol. 57, 1276–1282 (2012).
  CAS PubMed Google Scholar
• Wong, V. W. et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 59, 969–974 (2010).
  PubMed Google Scholar
• Jain, D., Nayak, N. C. & Saigal, S. Hepatocellular carcinoma in nonalcoholic fatty liver cirrhosis and alcoholic cirrhosis: risk factor analysis in liver transplant recipients. Eur. J. Gastroenterol. Hepatol. 24, 840–848 (2012).
  PubMed Google Scholar
• Hashimoto, E. & Tokushige, K. Hepatocellular carcinoma in non-alcoholic steatohepatitis: growing evidence of an epidemic? Hepatol. Res. 42, 1–14 (2012).
  PubMed Google Scholar
• Ascha, M. S. et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 51, 1972–1978 (2010).
  PubMed Google Scholar
• Bhala, N. et al. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology 54, 1208–1216 (2011).
  PubMed Google Scholar
• Cho, E. J. et al. Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area. Digestion 84 (Suppl 1.), 17–22 (2011).
  PubMed Google Scholar
• Kawamura, Y. et al. Large-scale long-term follow-up study of Japanese patients with non-alcoholic fatty liver disease for the onset of hepatocellular carcinoma. Am. J. Gastroenterol. 107, 253–261 (2012).
  CAS PubMed Google Scholar
• Adams, L. A. et al. The natural history of non-alcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129, 113–121 (2005).
  PubMed Google Scholar
• Chitturi, S. & Farrell, G. C. Clues from the carotids: An appraisal of cardiovascular disease risk in non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 24, 1311–1319 (2009).
  Google Scholar
• Stepanova, M. & Younossi, Z. M. Independent association between non-alcoholic fatty liver disease and cardiovascular disease in the US population. Clin. Gastroenterol. Hepatol. 10, 646–650 (2012).
  PubMed Google Scholar
• Hsaio, P. J. et al. Significant correlations between severe fatty liver and risk factors for metabolic syndrome. J. Gastroenterol. Hepatol. 22, 2118–2123 (2009).
  Google Scholar
• Wang, C. C. et al. Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 24, 1411–1416 (2009).
  PubMed Google Scholar
• Kim, D. et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology 56, 605–613 (2012).
  CAS PubMed Google Scholar
• Kim, B. J., Kim, N. H., Kim, B. S. & Kang, J. H. The association between non-alcoholic fatty liver disease, metabolic syndrome and arterial stiffness in nondiabetic, nonhypertensive individuals. Cardiology 123, 54–61 (2012).
  PubMed Google Scholar
• Wong, V. W. et al. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut 60, 1721–1727 (2011).
  CAS PubMed Google Scholar
• Calle E. E, Rodriguez, C., Walker-Thurmond, K. & Thun, M. J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of, U. S. adults. N. Engl. J. Med. 348, 1625–1638 (2003).
  PubMed Google Scholar
• Hwang, S. T. et al. Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps. J. Gastroenterol. Hepatol. 27, 91–95 (2010).
  Google Scholar
• Lee, Y. I., Lim, Y. S. & Park, H. S. Colorectal neoplasms in relation to non-alcoholic fatty liver disease in Korean women: a retrospective study. J. Gastroenterol. Hepatol. 25, 562–567 (2012).
  Google Scholar
• Wong, V. W. et al. High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. Gut 60, 829–836 (2011).
  PubMed Google Scholar
• Starley, B. Q., Calcagno, C. J. & Harrison, S. A. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 51, 1820–1832 (2010).
  PubMed Google Scholar
• Larsson, S. C. & Wolk, A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br. J. Cancer 97, 1005–1008 (2007).
  CAS PubMed PubMed Central Google Scholar
• Chen, C. L. et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 135, 111–121 (2008).
  CAS PubMed Google Scholar
• Welzel, T. M. et al. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology 54, 463–471 (2011).
  PubMed Google Scholar
• Promrat, K. et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 51, 121–129 (2010).
  CAS PubMed Google Scholar
• Lindström, J. et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368, 1673–1679 (2006).
  PubMed Google Scholar
• Dixon, J. B., Bhathal, P. S. & O'Brien, P. E. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histological improvement. Obes. Surg. 16, 1278–1286 (2008).
  Google Scholar
• Mathurin, P. et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology 137, 532–540 (2009).
  CAS PubMed Google Scholar
• Ratzui, V. et al. A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France. J. Hepatol. 57, 376–383 (2012).
  Google Scholar
• Athyros, V. G. et al. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet 376, 1916–1922 (2010).
  CAS PubMed Google Scholar
• Lonardo, A. & Loria, P. Potential for statins in the chemoprevention and management of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 27, 1654–1664 (2012).
  CAS PubMed Google Scholar
• Nielsen, S. F., Nordestgaard, B. G. & Bojesen, S. E. Statin use and reduced cancer-related mortality. N. Engl. J. Med. 367, 1792–1802 (2012).
  CAS PubMed Google Scholar
• Park, H. et al. Efficacy of long-term ezetimibe therapy in patients with non-alcoholic fatty liver disease. J. Gastroenterol. 46, 101–107 (2011).
  CAS PubMed Google Scholar
• Tanaka, N. et al. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J. Clin. Gastroenterol. 42, 413–418 (2008).
  CAS PubMed Google Scholar
• Satapathy, S. K., Sakhuja, P., Malhotra, V., Sharma, B. C. & Sarin, S. K. Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis. J. Gastroenterol. Hepatol. 22, 634–638 (2007).
  CAS PubMed Google Scholar
• Chitturi, S. & Farrell, G. C. TNF-α as therapeutic target in NASH: tried, but not yet proven. J. Gastroenterol. Hepatol. 22, 613–614 (2007).
  PubMed Google Scholar
• Madan, K. et al. Vitamin E-based therapy is effective in ameliorating transaminasemia in nonalcoholic fatty liver disease. Indian J. Gastroenterol. 24, 251–255 (2005).
  PubMed Google Scholar
• Hasegawa, T., Yoneda, M., Nakamura, K., Makino, I. & Terano, A. Plasma transforming growth factor-β1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment. Pharmacol. Ther. 15, 1667–1672 (2001).
  CAS PubMed Google Scholar
• Wang, C. L. et al. Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children. World J. Gastroenterol. 14, 1598–1602 (2008).
  CAS PubMed PubMed Central Google Scholar
• Ono, M. et al. Improvement of liver function parameters in patients with type 2 diabetes treated with thiazolidinediones. Metabolism 54, 529–532 (2005).
  CAS PubMed Google Scholar
• Hyogo, H. et al. Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property. Dig. Liver Dis. 44, 492–496 (2012).
  CAS PubMed Google Scholar
• Iwasaki, T. et al. Sitagliptin as a novel treatment agent for non-alcoholic fatty liver disease patients with type 2 diabetes mellitus. Hepatogastroenterology 58, 2103–2105 (2011).
  CAS PubMed Google Scholar
• Enjoji, M. et al. Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: a pilot study. Int. J. Mol. Med. 22, 521–527 (2008).
  CAS PubMed Google Scholar
• Zein, C. O. et al. Pentoxifylline improves non-alcoholic steatohepatitis: a randomized placebo-controlled trial. Hepatology 54, 1610–1619 (2011).
  CAS PubMed Google Scholar